Sitryx CEO Iain Kilty describes the biopharmaceutical industry effort to go beyond immunosuppression in autoimmune and ...

Sponsored genetic testing programs can run afoul of federal laws, including the FCA and AKS, if not designed correctly.

In this episode, Host Erin Harris sits down with Dr. Simrit Parmar, Founder of Cellenkos, to explore how the company is pioneering umbilical cord blood-derived Regulatory T cell (Treg) cell therapies ...

New treatment paradigms are making biopharma industry stakeholder communications more ambitious and complex. But they must ...

Two universities in North Carolina, known for their expanding research capabilities, have achieved the highest possible classification for doctoral universities. On February 13, East Carolina ...

Oxygen, crucial for cellular respiration, is affected by pressure variations within a bioreactor, with higher pressure at the bottom leading to increased oxygen solubility. This heterogeneity is ...

The onset of the new U.S. presidential administration brings with it sweeping changes to U.S. policy related to artificial intelligence (AI). As a first step, the Trump administration revoked the ...

Should aspiring biopharmaceutical leaders focus on deep specialization and expertise in a singular area, or seek new and variable experiences across different parts of the business, developing a ...

The job market is more competitive than ever. Candidates with years of specialized experience struggle to find roles, while employers increasingly demand both deep expertise and broad adaptability. As ...

This article is the second installment of a three-part series aimed at helping drug and device manufacturers better navigate and understand the VA and DOD health systems. The first installment in the ...